1. Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC)
   Pei-Wen Yang et al, 2019, Frontiers in Oncology CrossRef
2. AXL Inhibitors: Status of Clinical Development
   Sheena Bhalla et al, 2023, Current Oncology Reports CrossRef
3. Immune escape and metastasis mechanisms in melanoma: breaking down the dichotomy
   Carl A. Shirley et al, 2024, Frontiers in Immunology CrossRef
4. Qigesan inhibits esophageal cancer cell invasion and migration by inhibiting Gas6/Axl-induced epithelial-mesenchymal transition
   Lingyu Kong et al, 2020, Aging CrossRef